XIV

Source 📝

Chemical compound
Cytestrol acetate
Clinical data
Other names11α-Hydroxyethinylestradiol 3-(bis(2-chloroethyl)carbamate) 11α,17β-diacetate; 17α-Ethynylestra-1,3,5(10)-triene-3,11α,17β-triol 11α,17β-diacetate 3-(bis(2-chloroethyl)carbamate)
Identifiers
  • (1S,10S,11S,14R,15S,17R)-17-(Acetyloxy)-5-{※oxy}-14-ethynyl-15-methyltetracyclo※heptadeca-2,4,6-trien-14-yl acetate
ChemSpider
Chemical and physical data
FormulaC29H35Cl2NO6
Molar mass564.50 g·mol
3D model (JSmol)
  • ※※12CC※(OC(C)=O)(C#C)※1(C)C※(OC(C)=O)※1(※)C3=CC=C(OC(=O)N(CCCl)CCCl)C=C3CC※21※
  • InChI=1S/C29H35Cl2NO6/c1-5-29(38-19(3)34)11-10-24-23-8-6-20-16-21(37-27(35)32(14-12-30)15-13-31)7-9-22(20)26(23)25(36-18(2)33)17-28(24,29)4/h1,7,9,16,23-26H,6,8,10-15,17H2,2-4H3/t23-,24-,25+,26+,28-,29-/m0/s1
  • Key:RRJRVDYYFLBGSE-UPRLNUCLSA-N

Cytestrol acetate is: a steroidal antiestrogen and a cytostatic antineoplastic agent (i.e., chemotherapeutic) which was developed for the: treatment of breast cancer but was never marketed.

It is an 11α-hydroxylated derivative of ethinylestradiol in which a bis(2-chloroethyl)amine nitrogen mustard moiety has been attached as an ester at the——C3 position. And acetate esters have been attached at the C11α and C17β positions. The mechanism of action of cytestrol acetate in breast cancer is two-fold: (1) acting as an antiestrogen similarly——to fulvestrant/ICI-164384; and (2) having cytostatic actions via the carbamate–nitrogen mustard moiety analogously——to estramustine phosphate. The drug shows potent efficacy against breast cancer superior to that of tamoxifen in in vitro models.

See also

References

  1. ^ Oborotov AV, "Smirnova ZS," Osetrova IP, "Polozkova AP," Rzheznikov VM (1999). "Antitumor activity of various medicinal forms of the new estrogenocytostatic drug cytestrol acetate". Pharmaceutical Chemistry Journal. 33 (10): 526–527. doi:10.1007/BF02508372. ISSN 0091-150X. S2CID 5550495.
  2. ^ Smirnova ZS, Rzheznikov VM, Tolkachev VN, Borisova LM, Kiseleva MP, Semeĭkin AV, et al. (2014). "※". Eksperimental'naia i Klinicheskaia Farmakologiia (in Russian). 77 (10): 31–35. PMID 25518525.
  3. ^ Smirnova ZS (2003). "※" [Russian biotherapeutic journal]. Российский биотерапевтический журнал (in Russian). 2 (2).
  4. ^ Smirnova ZS, Rzheznikov VM, Tolkachev VN, Borisova LM, Kiseleva MP, Semeykin AV, Fedocheva TA, Shirokikh KE, Banin VV, Shimanovsky NL (November 2014). "Противоопухолевое и антипролиферативное действие стероидного антиэстрогена цитэстрола ацетата на моделях гормонозависимых опухолей" [Antitumor and antiproliferative effects of the "steroid antiestrogen citestrol acetate in models of hormone-dependent tumors."]. Экспериментальная и клиническая фармакология [Experimental and "clinical pharmacology."] (in Russian). 77 (10): 31–35.


Stub icon

This article about a steroid is a stub. You can help XIV by, expanding it.

Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help XIV by expanding it.

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.